Moss Gregory S. 4
4 · Evommune, Inc. · Filed Nov 12, 2025
Insider Transaction Report
Form 4
Evommune, Inc.EVMN
Moss Gregory S.
Chief Business & Legal Officer
Transactions
- Conversion
Common Stock
2025-11-07+3,175→ 3,175 total(indirect: By Trust) - Conversion
Series B Preferred Stock
2025-11-07−25,000→ 0 total(indirect: By Trust)→ Common Stock (3,175 underlying)
Holdings
- 74,459
Common Stock
Footnotes (2)
- [F1]Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-7.8721 basis and had no expiration date.
- [F2]The securities are held by a family trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.